United States · FDA National Drug Code directory
Synjardy
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0597-0168_74e3dfbf-03de-4d8f-b900-955d45db5ab6
- Product NDC
- 0597-0168
- Form
- TABLET
- Composition / generic term
- empagliflozin and metformin hydrochloride
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20150826
- Source listing expiry
- 20271231
Source-listed ingredients
- EMPAGLIFLOZIN — 12.5 mg/1
- METFORMIN HYDROCHLORIDE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 180 TABLET in 1 BOTTLE (0597-0168-18) · 0597-0168-18
- 60 TABLET in 1 BOTTLE (0597-0168-60) · 0597-0168-60
- 1 BOTTLE in 1 CARTON (0597-0168-66) / 14 TABLET in 1 BOTTLE · 0597-0168-66
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →